Italia markets closed

Dow Jones
38.862,45
+10,18(+0,03%)
Nasdaq
16.324,86
-24,39(-0,15%)
Nikkei 225
38.835,10
+599,03(+1,57%)
EUR/USD
1,0756
-0,0017(-0,16%)
Bitcoin EUR
58.786,21
-157,11(-0,27%)
CMC Crypto 200
1.304,76
-60,37(-4,42%)

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.

Aggiungi a watchlist

43,94

+0,04

(+0,08%)

In data: 03:02PM EDT. Mercato aperto.

I prezzi di scambio non provengono da tutti i mercati

Capitalizzazione	89,065B
Beta (5 anni mensile)	0,39
Rapporto PE (ttm)	N/D
EPS (ttm)	-3,10
Prossima data utili	26 lug 2024
Rendimento e dividendo (futuro)	2,40 (5,47%)
Data ex dividendo	04 apr 2024
Stima target 1A	48,57

Tutte

GlobeNewswire
Arbutus Appoints Two New Executives
Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri